Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
8th grade Avg
|
|
New words:
ago, andH, anniversary, antigenC, ASC, Asia, bacterium, breath, buildillumigene, bundled, calculated, cancellation, cancelled, choice, clarification, closure, commencing, consequential, director, disclosing, duodenal, exceed, factor, fast, fit, foot, footprint, GBS, GDH, illumigene, ImmuoCard, increasedillumigene®component, inillumigene®inventory, Innovation, installed, kit, Legionella, linked, low, million, mortality, nondeductible, nonowner, ofillumigene, ourillumigene®molecular, outlay, outright, ownership, package, partner, passage, peptic, placement, pneumoniaeandBordetella, population, proceed, profile, promotee, published, qualification, qualitative, Receipt, reorganization, reorganizing, restored, serology, shortened, slightly, South, sovereign, stay, stimulate, structure, submission, submitted, submittingillumigene, theillumigene®test, thereon, timeframe, transformed, travel, Unaudited, unrestricted, urea, USA
Removed:
AG, auction, automation, bring, Buzard, calendar, cardiac, consisted, created, custom, Darmstadt, dispose, Division, driven, earnout, efficiency, efficiently, emerging, exploiting, failed, final, forfeited, headcount, HpSA, ImmunoCardSTAT, improvement, invest, KGaA, Letter, long, Merck, modified, mutual, ofC, optimization, oversee, par, partnership, pattern, Platinum, Preferability, Premier, professional, recently, recombinant, recurring, satisfaction, season, standalone, strive, supplemented, support, Thornton, UBS, unrealized, Vybion
Filing tables
Filing exhibits
Related press release
VIVO similar filings
Filing view
External links
Exhibit 23
Consent of Independent Registered Public Accounting Firm
We have issued our report dated November 29, 2011, with respect to the consolidated financial statements, schedule, and internal control over financial reporting included in the Annual Report of Meridian Bioscience, Inc. on Form 10-K for the year ended September 30, 2011. We hereby consent to the incorporation by reference of said report in the Registration Statements of Meridian Bioscience, Inc. on Forms S-8 (File No. 333-155703, effective November 26, 2008, File No. 333-122554, effective February 4, 2005, File No. 333-122002, effective January 12, 2005, File No. 333-75312, effective December 17, 2001, File No. 333-74825, effective March 22, 1999).
/s/ GRANT THORNTON LLP
Cincinnati, Ohio
November 29, 2011
November 29, 2011